Comment on ‘Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer’
BJU International · 2026-07 · 138 (1) · 170-170
DOI: 10.1111/bju.70268 ↗Kurz gefasst
Leserbrief in der Zeitschrift BJU International, online erschienen am 06.04.2026. Verfasst von Vinod Kumar und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Allied Sciences, G D Goenka University, Sohna, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Medical and Allied Sciences, G D Goenka University, Sohna, India.
- SGT college of Pharmacy, SGT University, Gurugram, India.
Zitieren
APA
Kumar, V., & Kant, R. (2026). Comment on ‘Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer’. BJU International, 138(1), 170-170. https://doi.org/10.1111/bju.70268
Vancouver
Kumar V, Kant R. Comment on ‘Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer’. BJU International. 2026;138(1):170-170. doi:10.1111/bju.70268
BibTeX
@article{Kumar2026,
author = {Kumar, Vinod and Kant, Ravi},
title = {Comment on ‘Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer’},
journal = {BJU International},
year = {2026},
volume = {138},
number = {1},
pages = {170--170},
doi = {10.1111/bju.70268}
}
EUVIMED